Ethyl 2-bromopropionate → HCID 10413093, compound
Reaction equation
[C:1]1([CH2:7][O:8][C:9]([NH:11][CH:12]2[N:18]=[C:17]([C:19]3[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=3)[C:16]3[CH:25]=[CH:26][CH:27]=[CH:28][C:15]=3[NH:14][C:13]2=[O:29])=[O:10])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.Br[CH:31]([CH3:37])[C:32]([O:34][CH2:35][CH3:36])=[O:33]>>[CH2:35]([O:34][C:32](=[O:33])[CH2:31][CH2:37][N:14]1[C:15]2[CH:28]=[CH:27][CH:26]=[CH:25][C:16]=2[C:17]([C:19]2[CH:20]=[CH:21][CH:22]=[CH:23][CH:24]=2)=[N:18][CH:12]([NH:11][C:9]([O:8][CH2:7][C:1]2[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=2)=[O:10])[C:13]1=[O:29])[CH3:36]Participants
3
Procedure
The procedure of Example 134 was carried out using equivalent amounts of 1,3-dihydro-3-phenylmethyloxycarbonylamino-5-phenyl-2H-1,4-benzodiazepin-2one and ethyl bromopropionate. The product was purified by chromatography on silica gel (hexane-ethyl acetate elution). The combined product fractions were evaporated to dryness in vacuo and crystallized to give the title compound which was dried at 65° C.: m.p. 57°-59° C.
Workup
- customThe product was purified by chromatography on silica gel (hexane-ethyl acetate elution)
- customThe combined product fractions were evaporated to dryness in vacuo
- customcrystallized
Sources & evidence
- ORD record
- ord-222db4b3dee2420992e5b90ba8be5c68
- Source dataset
- uspto-grants-1991_04
- Patent number
- US05004741
Reaction notes
Loading…